Navigation Links
Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting
Date:5/26/2009

mbers with proapoptotic proteins and upregulating specific proapoptotic factors, AT-101 lowers the threshold for cancer cells to undergo apoptosis in various tumor types. In Phase I and Phase II trials, AT-101 has demonstrated single-agent cytoreductive activity in several cancers, including chronic lymphocytic leukemia (CLL), non-Hodgkins lymphoma (NHL), and prostate cancer. Phase II combination trials are ongoing in several cancers, including hormone-refractory prostate cancer and non-small cell lung cancer (with Taxotere(R)), B-cell malignancies (with Rituxan(R)), small cell lung cancer (with Hycamtin(R)), glioma (with Temodar(R), +/- chemoradiotherapy [XRT]) and esophageal cancer (with docetaxel, 5-fluorouracil and XRT).

About Ascenta Therapeutics

Ascenta Therapeutics, Inc. is a privately-held, clinical-stage biopharmaceutical company that discovers and develops new medicines for the treatment of cancer. The company is headquartered in Malvern, Pennsylvania, and has a preclinical research facility in Shanghai, China. Its technology, licensed from both the National Institutes of Health and the laboratory of Dr. Shaomeng Wang at the University of Michigan, is focused on discovering molecules that restore the natural potential for cancer cells to undergo cell death (apoptosis). Ascenta's lead agent, AT-101, is an orally-active small molecule pan Bcl-2 inhibitor (Bcl-2, Bcl-xL, and Mcl-1) currently in Phase 2 clinical trials in castrate resistant prostate cancer. The Company's preclinical pipeline includes the oral multi-IAP antagonist AT-406, and an HDM2-p53 inhibitor program.

For additional information on Ascenta Therapeutics, please visit the company's website at www.ascenta.com


'/>"/>
SOURCE Ascenta Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
2. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
3. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
4. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
5. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
6. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
7. Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Urea Cycle Disorders
8. Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
9. Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes
10. Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders
11. Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... , April 24, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, announced the Company ... on Tuesday, April 28, 2015 to discuss the 1st ... to listen to the call by dialing 1-888-346-3479. International ... Participants should ask to be joined into the IGI ...
(Date:4/24/2015)... April 24, 2015  Span-America Medical Systems, Inc. ... its fiscal 2015 second quarter results on Thursday, April ... The company will conduct a conference call ... to review the company,s financial and operating results for ... broadcast of the conference call will be available ...
(Date:4/24/2015)... Introduction of new ... tools for radiosurgery/SBRT   The "Elements" ... enhancing the workflow for difficult to treat indications ... - comes full circle with the introduction of ... Elements enable on-the-fly generation of consistent treatment plans ...
Breaking Medicine Technology:Brainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona 2
(Date:4/24/2015)... On February 21st, 2015, Per Wickstrom had the ... contributor Karen Salkin at Durkin Entertainment’s EcoLuxe Lounge, sponsored ... of which Wickstrom is the founder. Making appearances at ... EcoLuxe Lounge is a gathering of some of the ... and services. Among the many roles that she has ...
(Date:4/24/2015)... Anchor Health Administrators (Anchor), specialists in Long-Term Care ... exclusive agreement with LTC Solutions for All LLC (SFA) ... , Anchor has more than 18 years of experience ... and is currently the designated advocate for the American ... member benefit. , “I am very pleased to be ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 With years ... , UGA is now proud to be partnered with ... of 16,000 animals a year. This partnership has brought ... their animals. , After providing an in-house payment ... Medical Teaching Hospital (VMTH) wanted to increase financing options ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 “ Opera ” ... Report, which features the latest and coolest technology products available ... of NewsWatch, conducted the review and shared with viewers how ... Without web browsers, surfing the internet would not be in ... other and the Opera browser is no different. Celebrating their ...
(Date:4/24/2015)... April 24, 2015 Qualis Health, ... organizations, has published a new resource for practicing ... The guide to Quality and Resource Use Reports ... & Medicare Services (CMS) to help practices interpret ... streamline resources, and identify care coordination opportunities to ...
Breaking Medicine News(10 mins):Health News:Karen Salkin Talks with Per Wickstrom at the 2015 EcoLuxe Lounge and the "Salute to the Oscars" Celebration 2Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2Health News:A Web Browser That Connects over 350 Million People was Featured on NewsWatch Television 2Health News:Qualis Health Publishes Guide to Help Physician Practices Assess and Improve Quality 2
... variants in the DNA of 486 people infected with HIV that ... virus and delay the onset of full-blown AIDS. ... for an HIV vaccine that would work by boosting the protective ... bodys own immune system overcome an infection. One of the genes ...
... may have ended 150 years ago but that need not ... ambience in a majestic 17th century garden . ... has made known plans to open up a part of ... for weddings. ,The magnificently laid and maintained gardens, ...
... passed snide remarks about her, claiming that the actress is too ... Ashton Kutcher tied the knot in September 2005, and the actress ... ,Lesley Guynes, who is separated from Moores half-brother commented that the ... she was old. ,I think Demi is getting too ...
... study by researchers has claimed that Chinas desire to ... monkeys in their infancy in the Mount Huangshan Scenic ... ,According to National Geographic, the skyrocketing infant mortality of ... to a restricted range and regularly competing for corn ...
... toughen anti-smoking laws, restricting smoking in public places and ... further approved a Health and Family Welfare Ministry proposal ... Act in the first week of the monsoon session ... told reporters after a Cabinet meeting in New Delhi. ...
... food cravings and keeping them in check may be ... first six-month phase of the study provides new insights ... their role in weight control. ,Cravings are ... Susan Roberts, PhD, director of the USDA HNRCAs Energy ...
Cached Medicine News:Health News:Experts Identify Vaccine Target for HIV 2Health News:Experts Identify Vaccine Target for HIV 3Health News:Now You can Marry in a Mughal Ambience, If You Wish to 2Health News:Chinese Eco-tourism Causing Infanticide Among Tibetan Monkeys 2Health News:Government to Toughen Its Anti-smoking Laws 2Health News:Weight Management Achieved by Controlling and Not Suppressing Food Cravings 2
... BP 900 offers three magnifications ... routine practice, the BP 900 ... and progressive functionality. Two optional ... one for digital photography, are ...
... 400 System is an automated multiplexing platform ... SNP detection, pathogen sequence detection and pharmacogenetics ... be applied to an open and flexible ... be reused until all tests sites have ...
... for venous pressure monitoring, blood sampling, ... Turbo-Flo polyurethane PICC line sets offer:, ... Micropuncture Introducer Needle, Biocompatible ... trimmed to patient specific anatomy. Remove ...
Cable connections for 5 different adapters: Storz, ACMI, Pentax, Wolf and Olympus....
Medicine Products: